Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.H6: component code: 934 - reservoir health effect ¿ impact code: 2645- no patient involvement health effect ¿ clinical code: 4582- no clinical signs, symptoms or conditions medical device problem code: 1069 - break investigation findings: 3233 - results pending completion of investigation investigation conclusions: 11 - conclusion not yet available.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on november 21, 2023.Upon further investigation of the reported event, the following information is new and/or changed: a1 (added patient's identifier); d4 (additional device information - added exp date); g3 (date received by manufacturer) ; g6 (indication that this is a follow-up report) ; h2 (follow-up due to additional information and device evaluation) ; h3 (device evaluated by manufacturer) ; h4 (device manufacture date); h6 (identification of evaluation codes 10, 11, 3331, 3259, 4307).The returned sample was inspected upon receipt and confirmed the venous temp probe was broken.A representative retention sample was inspected for damage with no damage noted on the device.All capiox units are 100% visually inspected at several points in the production and packaging processes.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|